Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B
NCT00877149
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Compensated Chronic Hepatitis B
Interventions
DRUG:
telbivudine/LDT600
Sponsor
Novartis Pharmaceuticals